医学
淋巴结
血管瘤
核医学
PET-CT
前列腺癌
放射科
脾脏
骨盆
淋巴
正电子发射断层摄影术
病理
癌症
内科学
作者
Emmanouil Panagiotidis,Anna Paschali,Xanthi Xourgia,Vassiliki Chatzipavlidou
出处
期刊:Clinical Nuclear Medicine
[Ovid Technologies (Wolters Kluwer)]
日期:2020-10-15
卷期号:45 (12): 960-961
被引量:4
标识
DOI:10.1097/rlu.0000000000003310
摘要
Abstract A 62-year-old man with prostate cancer underwent both 18 F-PSMA-1007 and 18 F-fluorocholine PET/CT studies for biochemical recurrence. 18 F-PSMA-1007 PET/CT outperformed 18 F-fluorocholine PET/CT in detecting lymph node metastases in the pelvis and retroperitoneum, whereas the former showed a focus of increased uptake in the spleen not seen on 18 F-fluorocholine. The 18 F-PSMA-1007 –avid lesion corresponded to a splenic hemangioma, which was initially detected in an MRI scan 10 years ago, unchanged in size. This case shows different features of 18 F-PSMA-1007 and 18 F-fluorocholine uptake, in an incidentally detected splenic hemangioma, alerting PET/CT reports for possible pitfall.
科研通智能强力驱动
Strongly Powered by AbleSci AI